BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32143863)

  • 1. Diagnostic value of navigation-guided core needle biopsy in deep regions of the head and neck with focal FDG uptake on
    Gao Y; Wu WJ; Zheng L; Huang MW; Liu SM; Zhang JG
    J Craniomaxillofac Surg; 2020 May; 48(5):508-513. PubMed ID: 32143863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Core-Needle Biopsy and Fine-Needle Aspiration for Evaluating Thyroid Incidentalomas Detected by
    Suh CH; Choi YJ; Lee JJ; Shim WH; Baek JH; Chung HC; Shong YK; Song DE; Sung TY; Lee JH
    Thyroid; 2017 Oct; 27(10):1258-1266. PubMed ID: 28791924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of
    Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
    Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Kumar R; Mittal BR; Bhattacharya A; Singh H; Bal A; Prakash G; Singh N
    AJR Am J Roentgenol; 2019 Jan; 212(1):W10-W18. PubMed ID: 30383406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonography-guided core needle biopsy of cervical lymph nodes for diagnosing head and neck lymphoma compared with open surgical biopsy: Exploration for factors that shape diagnostic yield.
    Kwon M; Yim C; Baek HJ; Lee JS; Seo JH; Kim JP; Woo SH; Park JJ
    Am J Otolaryngol; 2018; 39(6):679-684. PubMed ID: 30055795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-guided core needle biopsy of deep suprahyoid head and neck lesions.
    Wu EH; Chen YL; Wu YM; Huang YT; Wong HF; Ng SH
    Korean J Radiol; 2013; 14(2):299-306. PubMed ID: 23482651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient.
    Lonneux M; Lawson G; Ide C; Bausart R; Remacle M; Pauwels S
    Laryngoscope; 2000 Sep; 110(9):1493-7. PubMed ID: 10983949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
    Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
    Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of
    Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
    Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
    [No Abstract]   [Full Text] [Related]  

  • 14. Prediction of ultrasound guided fine needle aspiration cytology results by FDG PET-CT for lymph node metastases in head and neck squamous cell carcinoma patients.
    Peltenburg B; de Keizer B; Dankbaar JW; de Boer M; Willems SM; Philippens MEP; Terhaard CHJ; de Bree R
    Acta Oncol; 2018 Dec; 57(12):1687-1692. PubMed ID: 30489180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
    Lee HS; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
    Eur J Radiol; 2014 Aug; 83(8):1455-60. PubMed ID: 24929443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET metabolic tumor parameters for the reirradiation of recurrent head and neck cancer.
    Velez MA; Veruttipong D; Wang PC; Abemayor E; St John M; TenNapel M; Chen AM
    Laryngoscope; 2018 Oct; 128(10):2345-2350. PubMed ID: 29573279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
    Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
    Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Han EJ; O JH; Yoo IR; Kim YS; Kim MS; Kang JH; Choi WH
    Hell J Nucl Med; 2017; 20(2):134-140. PubMed ID: 28697190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of suspected local recurrence in head and neck cancer: a comparison between PET and PET/CT for biopsy proven lesions.
    Halpern BS; Yeom K; Fueger BJ; Lufkin RB; Czernin J; Allen-Auerbach M
    Eur J Radiol; 2007 May; 62(2):199-204. PubMed ID: 17223003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.